Established in 2004, CD Genomics has updated its technology platform to mainstream NGS and microarray instruments and accumulated abundant experience with various analyzers. The company aims to satisfy the sequencing or array needs of pharmaceutical and biotech companies, academia, and government agencies. CD Genomics has expanded its services to molecular biology research and development needs and has satisfied clients in over 50 countries and districts.